BamSEC and AlphaSense Join Forces
Learn More

Trevi Therapeutics Inc.

NASDAQ: TRVI    
Share price (1/8/25): $4.03    
Market cap (1/8/25): $310 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.7
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.6
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.5
from S-3 61 pages Trevi Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 59 pages Trevi Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Trevi Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Pre-Funded Common Stock Purchase Warrant Trevi Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 18 pages Common Stock Purchase Warrant Trevi Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant Trevi Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 21 pages Common Stock Purchase Warrant Trevi Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 21 pages Common Stock Purchase Warrant Trevi Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 20 pages Pre-Funded Common Stock Purchase Warrant Trevi Therapeutics, Inc
12/34/56
EX-4.6
from S-3 8 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3 8 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 61 pages Trevi Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 59 pages Trevi Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.2
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1 2 pages Indenture or similar
12/34/56